NuGen Medical Devices Inc (TSE:NGMD) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NuGen Medical Devices Inc. has secured an initial purchase order from Sol-Millennium for 3,832 InsuJet™ needle-free injectors, targeting pharmacy launches in Canada and Switzerland. This deal, valued at $801,000, significantly outpaces NuGen’s full-year revenue for 2023 and marks a key step in the company’s growth within its major markets. The delivery of these devices, which is set to begin in August 2024, will also bolster NuGen’s gross margin by $448,000.
For further insights into TSE:NGMD stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money